These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6362878)

  • 1. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone in relapsed and refractory acute leukemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):32-5. PubMed ID: 6385263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
    Smith IE
    Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoxantrone in acute lymphoblastic leukemia.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():65-8. PubMed ID: 6581869
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.
    Prentice HG; Wimperis JZ; Robbins G
    Invest New Drugs; 1985; 3(2):207-12. PubMed ID: 3894280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone--a critique.
    Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():77-9. PubMed ID: 6661738
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.
    Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.
    Mouridsen HT; Rose C; Nooy MA; van Oosterom AT
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():47-52. PubMed ID: 6661734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Ehninger G; Ho AD; Meyer P; Mjaaland I; Ostendorf P; Seither E
    Onkologie; 1985 Jun; 8(3):146-8. PubMed ID: 3895096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic activity of mitoxantrone and ametantrone against murine tumors.
    Schabel FM; Corbett TH; Griswold DP; Laster WR; Trader MW
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():13-21. PubMed ID: 6362874
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Moore JO; Olsen GA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Meyer P; Ho AD; Ehninger G; Mjaaland I; Heidemann E; Seither E
    Invest New Drugs; 1985; 3(2):203-6. PubMed ID: 3860490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I-II trial of mitoxantrone in acute leukemia: an interim report.
    Arlin ZA; Dukart G; Schoch I; Reisman A; Moore J; Silver RA; Cassileth P; Bertino J; Gams R
    Invest New Drugs; 1985; 3(2):213-7. PubMed ID: 3860491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone in patients with acute leukemia in relapse.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 12010 and P 388 leukemia.
    Osswald H; Youssef M
    J Cancer Res Clin Oncol; 1986; 111(2):137-40. PubMed ID: 2939092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety and tolerance of mitoxantrone (Novantrone).
    Crossley RJ
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():29-36. PubMed ID: 6362875
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitoxantrone: a new anticancer drug with significant clinical activity.
    Shenkenberg TD; Von Hoff DD
    Ann Intern Med; 1986 Jul; 105(1):67-81. PubMed ID: 3521429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.